Seon-Wook Hwang
Algemeen Directeur bij NOVMETAPHARMA CO., LTD.
Vermogen: 5 M $ op 31-05-2024
Actieve functies van Seon-Wook Hwang
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
NOVMETAPHARMA CO., LTD. | Directeur/Bestuurslid | 04-11-2010 | - |
Algemeen Directeur | 04-11-2010 | - | |
President | - | - | |
NovMetaHealth Co. Ltd.
NovMetaHealth Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of NovMetaPharma Co., Ltd., NovMetaHealth Co. Ltd. develops and manufactures products related to metabolic diseases. The company is based in Seoul, South Korea. The South Korean company was founded in 2016. Seon-Wook Hwang has been the CEO of the company since 2016. NovMetaHealth Co. was acquired by NovMetaPharma Co., Ltd. on March 10, 2022 for $12.61 million. | Algemeen Directeur | 01-03-2016 | - |
PNC Holdings Co. Ltd. | Algemeen Directeur | 01-09-2015 | - |
Loopbaan van Seon-Wook Hwang
Opleiding van Seon-Wook Hwang
Chung-Ang University | Graduate Degree |
Statistieken
Internationaal
Zuid-Korea | 5 |
Operationeel
Chief Executive Officer | 3 |
Director/Board Member | 1 |
President | 1 |
Sectoraal
Health Technology | 3 |
Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
NOVMETAPHARMA CO., LTD. | Health Technology |
Bedrijven in privébezit | 2 |
---|---|
PNC Holdings Co. Ltd. | |
NovMetaHealth Co. Ltd.
NovMetaHealth Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of NovMetaPharma Co., Ltd., NovMetaHealth Co. Ltd. develops and manufactures products related to metabolic diseases. The company is based in Seoul, South Korea. The South Korean company was founded in 2016. Seon-Wook Hwang has been the CEO of the company since 2016. NovMetaHealth Co. was acquired by NovMetaPharma Co., Ltd. on March 10, 2022 for $12.61 million. | Health Technology |
- Beurs
- Insiders
- Seon-Wook Hwang
- Ervaring